Endo International PLC Company Profile (NASDAQ:ENDP)

About Endo International PLC

Endo International PLC logoEndo International PLC, formerly Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel. The Company operates in three segments: Endo Pharmaceuticals, Qualitest and AMS. In June 2014, the Company's subsidiary, Endo Pharmaceuticals sold its pharmaceutical drug discovery platform to AsanaBioSciences, LLC. In June 2014, Asana BioSciences, LLC, an independent member of Amneal Alliance of Companies, acquired early-stage branded pharmaceutical discovery platform of Endo Pharmaceuticals, a subsidiary of Endo International plc. In June 2014, Trendlines Group acquired intellectual property developed within the framework of an R&D agreement with the Company. In July 2014, it acquired Grupo Farmaceutico Somar.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: ENDP
  • CUSIP: 29264F20
Key Metrics:
  • Previous Close: $20.81
  • 50 Day Moving Average: $20.59
  • 200 Day Moving Average: $20.24
  • 52-Week Range: $12.56 - $68.84
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 4.20
  • P/E Growth: 1.06
  • Market Cap: $4.64B
  • Outstanding Shares: 222,766,000
  • Beta: 0.79
  • Net Margins: -25.90%
  • Return on Equity: 15.54%
  • Return on Assets: 4.93%
  • Debt-to-Equity Ratio: 1.31%
  • Current Ratio: 0.90%
  • Quick Ratio: 0.69%
Additional Links:
Companies Related to Endo International PLC:

Analyst Ratings

Consensus Ratings for Endo International PLC (NASDAQ:ENDP) (?)
Ratings Breakdown: 1 Sell Rating, 9 Hold Ratings, 10 Buy Ratings
Consensus Rating:Hold (Score: 2.45)
Consensus Price Target: $37.05 (78.04% upside)

Analysts' Ratings History for Endo International PLC (NASDAQ:ENDP)
DateFirmActionRatingPrice TargetDetails
10/15/2016GuggenheimReiterated RatingBuy$35.00View Rating Details
9/29/2016Northland SecuritiesUpgradeMarket Perform -> Outperform$27.00View Rating Details
9/29/2016MizuhoReiterated RatingOutperform -> Sell$29.00View Rating Details
9/27/2016Oppenheimer Holdings Inc.Reiterated RatingMarket PerformView Rating Details
9/27/2016Piper Jaffray Cos.Reiterated RatingNeutral$19.00View Rating Details
9/23/2016Leerink SwannReiterated RatingMarket Perform$22.00View Rating Details
9/16/2016Citigroup Inc.Lower Price TargetBuy$40.00 -> $25.00View Rating Details
9/8/2016Morgan StanleySet Price TargetHold$15.00 -> $16.00View Rating Details
8/9/2016JPMorgan Chase & Co.Set Price TargetBuy$40.00View Rating Details
8/9/2016BMO Capital MarketsReiterated RatingHold$22.00View Rating Details
6/29/2016Deutsche Bank AGReiterated RatingBuy$30.00View Rating Details
6/29/2016JMP SecuritiesReiterated RatingBuyView Rating Details
6/6/2016Goldman Sachs Group Inc.Initiated CoverageNeutral$20.00View Rating Details
5/18/2016Royal Bank Of CanadaReiterated RatingSector Perform$26.00View Rating Details
5/18/2016Stifel NicolausLower Price TargetBuy$75.00 -> $25.00View Rating Details
5/8/2016Barclays PLCReiterated RatingHoldView Rating Details
4/2/2016NomuraReiterated RatingBuyView Rating Details
3/18/2016William BlairReiterated RatingHold$35.00View Rating Details
3/1/2016Canaccord GenuityReiterated RatingBuy$67.00View Rating Details
11/20/2015SusquehannaLower Price Target$70.00 -> $68.00View Rating Details
11/13/2015Standpoint ResearchUpgradeHold -> Buy$75.00View Rating Details
6/3/2015Raymond James Financial Inc.Initiated CoverageMarket PerformView Rating Details
5/22/2015Cantor FitzgeraldBoost Price TargetHold$80.00 -> $92.00View Rating Details
3/3/2015Keefe, Bruyette & WoodsBoost Price TargetOutperform$94.00 -> $101.00View Rating Details
2/2/2015CRT CapitalBoost Price TargetFair Value$73.00 -> $80.00View Rating Details
(Data available from 10/24/2014 forward)


Earnings History for Endo International PLC (NASDAQ:ENDP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016ListenView Earnings Details
8/8/2016Q216$0.74$0.86$873.50 million$921.00 millionViewListenView Earnings Details
5/5/2016Q116$1.04$1.08$960.96 million$963.54 millionViewListenView Earnings Details
2/29/2016Q415$1.27$1.36$1.07 billion$1.07 billionViewListenView Earnings Details
11/5/2015Q315$1.00$1.02$736.16 million$746.00 millionViewListenView Earnings Details
8/10/2015Q215$1.02$1.08$727.45 million$735.00 millionViewListenView Earnings Details
5/11/2015Q115$1.07$1.17$714.42 million$714.00 millionViewListenView Earnings Details
3/2/2015Q414$1.12$1.16$780.44 million$800.00 millionViewListenView Earnings Details
11/5/2014Q314$0.99$1.15$721.11 million$764.00 millionViewListenView Earnings Details
7/31/2014Q214$0.88$1.06$644.60 million$719.00 millionViewListenView Earnings Details
5/1/2014Q114$0.84$0.92$608.86 million$595.00 millionViewListenView Earnings Details
2/28/2014Q413$0.93$0.96$620.90 million$584.95 millionViewListenView Earnings Details
11/7/2013Q313$1.11$1.34$695.63 million$715.00 millionViewListenView Earnings Details
8/6/2013Q2 2013$1.15$1.42$721.01 million$766.51 millionViewListenView Earnings Details
5/7/2013Q1 2013$1.08$1.09$737.79 million$709.00 millionViewListenView Earnings Details
2/28/2013Q4 2012$1.54$1.62$807.98 million$801.06 millionViewListenView Earnings Details
11/5/2012Q312$1.26$1.28$788.53 million$750.50 millionViewN/AView Earnings Details
8/7/2012$1.19$1.27ViewN/AView Earnings Details
5/1/2012$0.86$0.87ViewN/AView Earnings Details
2/24/2012$1.32$1.40ViewN/AView Earnings Details
10/27/2011$1.28$1.25ViewN/AView Earnings Details
8/9/2011$1.06$1.05ViewN/AView Earnings Details
4/28/2011$1.00$1.00ViewN/AView Earnings Details
2/28/2011$0.97$1.06ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Endo International PLC (NASDAQ:ENDP)
Current Year EPS Consensus Estimate: $4.56 EPS
Next Year EPS Consensus Estimate: $4.96 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164$1.05$1.15$1.09
Q2 20163$0.74$1.24$0.92
Q3 20163$0.80$0.85$0.82
Q4 20163$1.75$1.85$1.80
Q1 20171$1.61$1.61$1.61
Q2 20171$1.24$1.24$1.24
Q3 20171$1.10$1.10$1.10
Q4 20171$1.12$1.12$1.12
(Data provided by Zacks Investment Research)


Dividend History for Endo International PLC (NASDAQ:ENDP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Endo International PLC (NASDAQ:ENDP)
Insider Ownership Percentage: 0.70%
Institutional Ownership Percentage: 96.54%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/11/2016Arthur J HigginsDirectorBuy5,000$13.80$69,000.00View SEC Filing  
5/10/2016Arthur J HigginsDirectorBuy11,000$15.42$169,620.00View SEC Filing  
5/10/2016Paul CampanelliInsiderBuy13,000$15.53$201,890.00View SEC Filing  
3/17/2016William SpenglerDirectorBuy1,000$29.20$29,200.00View SEC Filing  
3/16/2016William SpenglerDirectorBuy1,000$35.24$35,240.00View SEC Filing  
3/14/2016Roger H KimmelDirectorBuy1,125$41.94$47,182.50View SEC Filing  
3/7/2016Matthew Joseph MalettaVPBuy500$44.48$22,240.00View SEC Filing  
3/7/2016Silva Rajiv DeCEOBuy2,250$44.50$100,125.00View SEC Filing  
3/1/2016Nancy J. HutsonDirectorSell3,413$42.19$143,994.47View SEC Filing  
11/12/2015Shane CookeDirectorBuy4,000$57.13$228,520.00View SEC Filing  
11/11/2015Michael HyattDirectorSell8,000$55.48$443,840.00View SEC Filing  
11/11/2015Paul CampanelliinsiderBuy2,100$55.69$116,949.00View SEC Filing  
11/11/2015Silva Rajiv DeCEOBuy9,006$55.52$500,013.12View SEC Filing  
11/11/2015Suketu UpadhyayCFOBuy4,450$56.37$250,846.50View SEC Filing  
11/11/2015Susan HallEVPBuy1,000$55.35$55,350.00View SEC Filing  
6/16/2015Arthur J HigginsDirectorBuy2,500$81.10$202,750.00View SEC Filing  
4/8/2015Caroline B ManogueVPSell105,562$91.90$9,701,147.80View SEC Filing  
11/14/2014Suketu UpadhyayCFOBuy3,700$66.94$247,678.00View SEC Filing  
8/5/2014Arthur J HigginsDirectorBuy3,500$65.65$229,775.00View SEC Filing  
6/9/2014John DeluccaDirectorSell6,764$68.83$465,566.12View SEC Filing  
5/29/2014Caroline B ManogueVPSell175,033$72.02$12,605,876.66View SEC Filing  
5/1/2014John DeluccaDirectorSell8,094$66.31$536,713.14View SEC Filing  
4/1/2014John DeluccaDirectorSell10,384$68.46$710,888.64View SEC Filing  
3/10/2014Arthur HigginsDirectorBuy5,000$73.00$365,000.00View SEC Filing  
3/10/2014Ivan GergelEVPSell75,637$72.47$5,481,413.39View SEC Filing  
8/26/2013Caroline ManogueVPSell145,592$39.40$5,736,324.80View SEC Filing  
8/8/2013Roger KimmelDirectorBuy5,478$36.50$199,947.00View SEC Filing  
4/9/2013Caroline B ManogueVPSell35,000$35.00$1,225,000.00View SEC Filing  
11/12/2012David HolveckCEOBuy7,425$26.84$199,287.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Endo International PLC (NASDAQ:ENDP)
smarteranalyst.com logoCompany Update (NASDAQ:ENDP): Endo International plc ... - Smarter Analyst (NASDAQ:ENDP)
www.smarteranalyst.com - October 21 at 6:12 AM
seekingalpha.com logoEndo finance chief to depart next month (NASDAQ:ENDP)
seekingalpha.com - October 20 at 10:13 PM
smarteranalyst.com logoCompany Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares Announces Departure of Chief Financial Officer (NASDAQ:ENDP)
www.smarteranalyst.com - October 20 at 4:48 PM
publicnow.com logoEndo Announces Departure of Chief Financial Officer (NASDAQ:ENDP)
www.publicnow.com - October 20 at 4:48 PM
4-traders.com logoUniversal Health Services : Healthcare Stocks on Investors' Radar -- Endo, Teva Pharma, Ionis Pharma, and Universal Health Services (NASDAQ:ENDP)
www.4-traders.com - October 19 at 5:14 PM
News IconInvestors Recap - Endo International plc's (ENDP) - Hot Stocks Point (NASDAQ:ENDP)
www.hotstockspoint.com - October 18 at 9:50 AM
publicnow.com logoEndo to Announce Third Quarter 2016 Financial Results on November 8, 2016 (NASDAQ:ENDP)
www.publicnow.com - October 18 at 9:50 AM
marketrealist.com logoValeant’s Reorganization Efforts Could Boost Investor Confidence (NASDAQ:ENDP)
marketrealist.com - October 17 at 4:49 PM
News IconWhat are analysts Suggestions on: Endo International plc (NASDAQ:ENDP) (NASDAQ:ENDP)
thelakeandeswave.com - October 15 at 9:41 AM
News IconUpdate on Endo International plc (NASDAQ:ENDP) for the day (NASDAQ:ENDP)
twincountynews.com - October 15 at 9:41 AM
stocksdaily.net logoEndo International plc (NASDAQ:ENDP) EPS Target At $0.81? - Stocks Daily (NASDAQ:ENDP)
www.stocksdaily.net - October 13 at 12:29 PM
News IconMost Volatile Market Movers: Endo International plc (NASDAQ:ENDP), Vertex Pharmaceuticals Incorporated (NASDAQ ... - Street Wise Report (press release) (blog) (NASDAQ:ENDP)
streetwisereport.com - October 13 at 12:29 PM
News IconTraders Watch list: Gramercy Property Trust (NYSE:GPT), Endo International plc - Ordinary Shares (NASDAQ:ENDP ... - NYSE Journal (press release) (NASDAQ:ENDP)
stockznews.com - October 12 at 3:18 PM
News IconEndo International plc's (ENDP): Stock in the Traders Limelight - Hot Stocks Point (NASDAQ:ENDP)
www.hotstockspoint.com - October 12 at 3:18 PM
cnbc.com logoThese are the cheapest stocks in the market—but beware a value trap: Technician (NASDAQ:ENDP)
www.cnbc.com - October 12 at 3:18 PM
finance.yahoo.com logoEndo receives a vote of confidence (NASDAQ:ENDP)
finance.yahoo.com - October 11 at 4:59 PM
realistinvestor.com logoEndo International plc (NASDAQ:ENDP) Accounts Payable At $344.267 Millions - RealistInvestor.com (NASDAQ:ENDP)
www.realistinvestor.com - October 9 at 9:23 AM
News IconValuable Sizzling Stock of Yesterday- Endo International plc's ... - Hot Stocks Point (NASDAQ:ENDP)
www.hotstockspoint.com - October 7 at 9:47 AM
blogs.barrons.com logoSpecialty Pharma: Drug Pricing Controversies Just Won't Die! (NASDAQ:ENDP)
blogs.barrons.com - October 6 at 4:46 PM
News IconEndo International plc's (ENDP): Popular Mover to Observe - Hot Stocks Point (NASDAQ:ENDP)
www.hotstockspoint.com - October 5 at 10:00 AM
News IconEndo International plc – Ordinary Shares (NASDAQ:ENDP) & Liberty ... - Money News (NASDAQ:ENDP)
www.newsismoney.com - October 4 at 4:46 PM
capitalcube.com logoEndo International Plc – Value Analysis (NASDAQ:ENDP) : October 4, 2016 (NASDAQ:ENDP)
www.capitalcube.com - October 4 at 4:46 PM
News IconStocks in Focus: Endo International plc - Ordinary Shares (NASDAQ:ENDP), Halliburton Company (NYSE:HAL) - NYSE Journal (press release) (NASDAQ:ENDP)
stockznews.com - October 4 at 9:39 AM
zacks.com logoEndo International Reports Positive Phase II Data on Xiaflex (NASDAQ:ENDP)
www.zacks.com - October 3 at 4:38 PM
capitalcube.com logoEndo International Plc breached its 50 day moving average in a Bearish Manner : ENDP-US : October 3, 2016 (NASDAQ:ENDP)
www.capitalcube.com - October 3 at 9:34 AM
realistinvestor.com logoEndo International plc (NASDAQ:ENDP) Accounts Payable At $318.459 - RealistInvestor.com (NASDAQ:ENDP)
www.realistinvestor.com - October 1 at 4:29 PM
News IconWhat Analysts Recommend on Endo International plc - Ordinary Shares (NASDAQ:ENDP)? - Post Registrar (NASDAQ:ENDP)
postregistrar.com - October 1 at 4:29 PM
finance.yahoo.com logo7:30 am Endo Intl presents new phase 2 data evaluating the safety and effectiveness of Xiaflex for dupuytren's disease nodules (NASDAQ:ENDP)
finance.yahoo.com - October 1 at 4:29 PM
News IconInvestor's Alert: Sally Beauty Holdings, Inc. (NYSE:SBH), Endo International plc - Ordinary Shares (NASDAQ:ENDP) - NYSE Journal (press release) (NASDAQ:ENDP)
stockznews.com - September 30 at 5:11 PM
smarteranalyst.com logoCompany Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares Presents New Phase 2 Data of XIAFLEX ... - Smarter Analyst (NASDAQ:ENDP)
www.smarteranalyst.com - September 30 at 5:11 PM
smarteranalyst.com logoMizuho Weighs in on Endo International plc – Ordinary Shares (ENDP) Following Analyst Event - Smarter Analyst (NASDAQ:ENDP)
www.smarteranalyst.com - September 30 at 5:11 PM
marketrealist.com logoWhat Are Analysts Saying about Mallinckrodt? (NASDAQ:ENDP)
marketrealist.com - September 30 at 5:11 PM
smarteranalyst.com logoCompany Update (NASDAQ:ENDP): Endo International plc – Ordinary Shares Presents New Phase 2 Data of XIAFLEX for Dupuytren’s Disease Nodules (NASDAQ:ENDP)
www.smarteranalyst.com - September 30 at 9:55 AM
finance.yahoo.com logoEndo Intl upgraded by Northland Capital (NASDAQ:ENDP)
finance.yahoo.com - September 29 at 4:47 PM
News IconMarket Traders Alert - Endo International plc (NASDAQ:ENDP) (NASDAQ:ENDP)
thelakeandeswave.com - September 29 at 9:51 AM
biz.yahoo.com logoENDO INTERNATIONAL PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi (NASDAQ:ENDP)
biz.yahoo.com - September 29 at 9:51 AM
News IconHottest European Stocks Now: Alkermes plc (ALKS), Endo ... - The Independent Republic (NASDAQ:ENDP)
theindependentrepublic.com - September 28 at 4:42 PM
News IconHC Stocks Impression! Novavax, Inc. (NVAX), Endo International plc (NASDAQ:ENDP) - share market updates (press release) (NASDAQ:ENDP)
sharemarketupdates.com - September 27 at 4:50 PM
streetinsider.com logoOppenheimer Remains Sidelined Following Endo Int'l's (ENDP) New CEO Appointment (NASDAQ:ENDP)
www.streetinsider.com - September 27 at 9:26 AM
finance.yahoo.com logoEndo Appoints New CEO, Keeps Q3 & '16 View, Stock Jumps (NASDAQ:ENDP)
finance.yahoo.com - September 26 at 4:59 PM
blogs.barrons.com logoEndo: The Good Feelings Didn't Last Long, Did They? (NASDAQ:ENDP)
blogs.barrons.com - September 26 at 4:59 PM
thestreet.com logoEndo (ENDP) Stock Slumps, Oppenheimer: 'Not Surprised' by CEO Change (NASDAQ:ENDP)
www.thestreet.com - September 26 at 4:59 PM
thestreet.com logoChanges at the Top for Endo Could Benefit Its Smaller Partners (NASDAQ:ENDP)
www.thestreet.com - September 26 at 9:33 AM
News IconBlog Coverage Change in Leadership at Endo Pharma (NASDAQ:ENDP)
news.investornetwork.com - September 26 at 9:33 AM
reuters.com logoEndo International CEO steps down; Campanelli named successor (NASDAQ:ENDP)
www.reuters.com - September 24 at 9:28 AM
News IconEndo International (ENDP) Is Climbing After New CEO Named (NASDAQ:ENDP)
myhealthbowl.com - September 24 at 9:28 AM
marketwatch.com logoEndo CEO De Silva steps down, replaced by former Par CEO - MarketWatch (NASDAQ:ENDP)
www.marketwatch.com - September 23 at 4:36 PM
ft.com logo[$$] Drugmaker Endo rises on leadership change (NASDAQ:ENDP)
www.ft.com - September 23 at 4:36 PM
finance.yahoo.com logoPharma ETF Looks Healthy in a Sick Market After Endo Names New CEO (NASDAQ:ENDP)
finance.yahoo.com - September 23 at 4:36 PM
cnbc.com logoEndo shares boosted by new CEO, upbeat guidance (NASDAQ:ENDP)
www.cnbc.com - September 23 at 4:36 PM


Endo International PLC (NASDAQ:ENDP) Chart for Monday, October, 24, 2016

Last Updated on 10/24/2016 by MarketBeat.com Staff